APA (7th ed.) Citation

ARSLANIAN, S. A., CHO, J. I., HANNON, T. S., ZEITLER, P., CHAO, L., BARRIENTOS, M., . . . COX, D. (2022). 5-LB: Dulaglutide in Youth with Type 2 Diabetes (T2D) —Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial. Diabetes (New York, N.Y.), 71(Supplement_1), . https://doi.org/10.2337/db22-5-LB

Chicago Style (17th ed.) Citation

ARSLANIAN, SILVA A., et al. "5-LB: Dulaglutide in Youth with Type 2 Diabetes (T2D) —Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial." Diabetes (New York, N.Y.) 71, no. Supplement_1 (2022). https://doi.org/10.2337/db22-5-LB.

MLA (9th ed.) Citation

ARSLANIAN, SILVA A., et al. "5-LB: Dulaglutide in Youth with Type 2 Diabetes (T2D) —Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial." Diabetes (New York, N.Y.), vol. 71, no. Supplement_1, 2022, https://doi.org/10.2337/db22-5-LB.